Home › Research › Brain tissue and pathology
Bridging the Gap: Can Hippocampal Sclerosis Serve as a Surrogate Biomarker for LATE‐NC?
Vítor Ribeiro Paes, Alberto Fernando Oliveira Justo, Caroline Matos Silva, Roberta Rodriguez, Renata Elaine Paraízo Leite, Cláudia Kimie Suemoto, Carlos Augusto Pasqualucci, Eduardo Ferriolli et al.. Alzheimer s & Dementia, 2025-12-01
Topic: Brain proteins, microglia and lab models
Among 1,307 individuals, 36.9% were non-White and 49.7% were women. HS was identified in 41 participants (3.1%), with higher prevalence among older individuals, women, and those with lower education levels (p < 0.001). HS was also significantly associated with hyaline arteriolosclerosis (p = 0.001) and diabetes mellitus (p = 0.003) (Table 1). Multivariate analysis confirmed associations between HS and LATE-NC (p < 0.001) as well as lacunar infarcts (p = 0.031) (Table 2). The positive predictive value (PPV) of HS for TDP- 43 pathology was 48.8%, increasing to 59.4% among cognitively impaired individuals (n = 432) (Table 3). Among individuals with HS but no TDP-43 pathology (n = 21), 48.4% had Braak-AD stage ≥3, and 64.5% exhibited arteriolosclerosis. HS is relatively uncommon in this population-based brain bank but is strongly associated with TDP-43 pathology. However, vascular pathology also plays a significant role, particularly in populations with high cardiovascular risk. This limits its predictive value for LATE-NC, even among cognitively impaired individuals. Given the absence of an in vivo biomarker for LATE-NC, further research is needed to determine whether MRI-detectable HS can serve as a reliable surrogate marker for LATE-NC pathology, particularly in genetically diverse populations with multiple comorbidities.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Paes, V. R., Justo, A. F. O., Silva, C. M., Rodriguez, R., Leite, R. E. P., Suemoto, C. K., et al. (2025). Bridging the Gap: Can Hippocampal Sclerosis Serve as a Surrogate Biomarker for LATE‐NC? Alzheimer s & Dementia. https://doi.org/10.1002/alz70856_107174
Vancouver
Paes VR, Justo AFO, Silva CM, Rodriguez R, Leite REP, Suemoto CK, et al. Bridging the Gap: Can Hippocampal Sclerosis Serve as a Surrogate Biomarker for LATE‐NC? Alzheimer s & Dementia. 2025. doi:10.1002/alz70856_107174. PMID: 41499176.
BibTeX
@article{paes2025-41499176,
author = {Paes, Vítor Ribeiro and Justo, Alberto Fernando Oliveira and Silva, Caroline Matos and Rodriguez, Roberta and Leite, Renata Elaine Paraízo and Suemoto, Cláudia Kimie and Pasqualucci, Carlos Augusto and Ferriolli, Eduardo and others},
title = {{Bridging the Gap: Can Hippocampal Sclerosis Serve as a Surrogate Biomarker for LATE‐NC?}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70856_107174},
pmid = {41499176},
url = {https://doi.org/10.1002/alz70856_107174}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Among 1,307 individuals, 36.9% were non-White and 49.7% were women.
- HS was identified in 41 participants (3.1%), with higher prevalence among older individuals, women, and those with lower education levels (p < 0.001).
- HS was also significantly associated with hyaline arteriolosclerosis (p = 0.001) and diabetes mellitus (p = 0.003) (Table 1).
- Multivariate analysis confirmed associations between HS and LATE-NC (p < 0.001) as well as lacunar infarcts (p = 0.031) (Table 2).
- The positive predictive value (PPV) of HS for TDP- 43 pathology was 48.8%, increasing to 59.4% among cognitively impaired individuals (n = 432) (Table 3).
Why it matters
In a brain bank of 1,307 individuals, hippocampal sclerosis was strongly associated with TDP-43 pathology, but its positive predictive value for TDP-43 pathology was only 48.8%, rising to 59.4% among cognitively impaired individuals, and vascular pathology also played a significant role. The authors conclude this limits its predictive value for LATE-NC and call for further research, so it does not provide a treatment, cure or prevention.
Study details
- Participants432
- Effect size36.9%; 49.7%; 3.1%
- Evidence strengthLow
How this study scored 43/100
Published in a peer-reviewed journal. Scored zero for study design and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 432 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Lea T. Grinberg: h-index 97 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of California, San Francisco: institution h-index 1,915 (OpenAlex) |
| Multi-centre collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41499176) |
| Free to read | 2 / 2 | Free to read |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70856_107174
- PubMed: 41499176
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related studies in Brain tissue and pathology
Also tagged “disorder”
492 studies in the library carry the topic tag “disorder”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 492 tagged studies.